Coccidiosis in Calves: Diagnosis, Treatment, and Farm Management

Introduction and Etiology

Bovine coccidiosis is a protozoal enteric disease caused by apicomplexan parasites of the genus Eimeria (phylum Apicomplexa, family Eimeriidae). The disease represents one of the most economically significant parasitic conditions affecting pre-weaned and post-weaned calves worldwide, ranking as the third most important parasitic disease in cattle after gastrointestinal nematodosis and fasciolosis [7]. Coccidiosis results from the intracellular parasitism of intestinal epithelial cells by sporozoites, meronts, and gamonts, leading to enteritis, malabsorption, hemorrhagic diarrhea, and in severe cases, mortality [15, 28].

The global prevalence of Eimeria spp. infection in calves has been systematically estimated through meta-analytical approaches, revealing infection rates that vary considerably by geographic region, management system, and diagnostic methodology [28]. In tropical and subtropical production systems, prevalence rates frequently exceed 50 percent in young stock, with particularly high burdens observed in confined or semi-confined rearing operations [3, 20].

Eimeria Species Infecting Cattle

At least 13 species of Eimeria have been described in Bos taurus and Bos indicus cattle, although not all species are equally pathogenic. The most clinically relevant species include Eimeria bovis, Eimeria zuernii, and Eimeria alabamensis, with E. bovis and E. zuernii accounting for the majority of clinical outbreaks [2, 3, 8, 28]. Species identification is based on oocyst morphology, including size, shape, color, and the presence or absence of micropyles and polar caps after sporulation in 2.5 percent potassium dichromate solution [3].

Table 1. Principal Pathogenic Eimeria Species in Cattle

Mixed infections involving two or more species are common in field conditions [3, 13]. The concurrent detection of multiple Eimeria species in a single fecal sample is associated with increased oocyst shedding intensity and greater likelihood of clinical disease [30].

Epidemiology and Economic Impact

Coccidiosis imposes substantial economic losses on cattle operations through multiple mechanisms: direct mortality, reduced weight gain, decreased feed conversion efficiency, veterinary treatment costs, and increased susceptibility to secondary bacterial and viral infections [7, 10, 19]. The economic burden is particularly severe in intensive rearing systems where high stocking densities and contaminated environments facilitate oocyst accumulation and re-infection.

Epidemiological risk factors for bovine coccidiosis include calf age (peak incidence between 3 weeks and 6 months), season (winter coccidiosis outbreaks are well documented in temperate regions), housing conditions (confinement on contaminated bedding), and management practices such as group mixing and lack of routine coprological monitoring [2, 3, 8, 9]. Protective factors include routine fecal examination and implementation of targeted deworming protocols [3].

A systematic review and meta-analysis encompassing studies from multiple continents confirmed that E. bovis and E. zuernii are the predominant species globally, with pooled prevalence estimates of 24.6 percent and 18.3 percent respectively [28]. The analysis further identified that weaned calves and animals housed in confined systems carry significantly higher odds of infection compared to grazing stock.

Pathogenesis and Clinical Signs

The life cycle of Eimeria spp. in cattle is monoxenous and involves both asexual (merogony) and sexual (gametogony) phases within the intestinal epithelium, followed by environmental sporulation of excreted oocysts. After ingestion of sporulated oocysts, sporozoites excyst in the small intestine, invade enterocytes, and undergo multiple rounds of merogony. The release of merozoites and the formation of macrogamonts and microgamonts cause progressive epithelial destruction, villous atrophy, crypt hyperplasia, and inflammatory infiltration of the lamina propria [15, 24].

Clinical manifestations range from subclinical infection (reduced growth performance without overt diarrhea) to acute enteritis characterized by watery to hemorrhagic diarrhea, tenesmus, dehydration, anorexia, and weight loss [5, 13, 17]. In peracute cases, calves may present with nervous signs including muscle tremors, ataxia, opsithotonos, and lateral recumbency, a syndrome termed "nervous coccidiosis" that has been associated with hypomagnesemia and hypocalcemia secondary to intestinal malabsorption [24].

Hematological alterations in calves with coccidiosis include decreased erythrocyte counts, reduced hemoglobin concentrations, and altered leukocyte profiles, reflecting the combined effects of intestinal hemorrhage and systemic inflammatory response [17]. Serum biomarkers of intestinal epithelial injury, including intestinal fatty acid binding protein (I-FABP), claudin-3 (CLD-3), and trefoil factor-3 (TFF-3), are significantly elevated in infected calves and correlate with disease severity [12].

Diagnosis

Fecal Examination Techniques

The cornerstone of coccidiosis diagnosis remains the quantitative enumeration of oocysts in fecal samples. The McMaster counting chamber technique, using saturated sodium chloride or Sheather sugar solution as flotation medium, is the standard method for estimating oocysts per gram (OPG) of feces [1, 3, 4, 12]. The technique involves homogenization of a known weight of feces in flotation solution, filtration through cheesecloth or a tea strainer, loading of the Mcmaster chamber, and microscopic enumeration of oocysts at 100x or 200x magnification.

Fecal flotation using zinc sulfate or sucrose solutions provides qualitative detection of oocysts and is suitable for screening purposes. The sensitivity of flotation methods is improved by centrifugation (flotation-centrifugation technique) compared to simple sedimentation [14]. For species identification, oocysts are allowed to sporulate in 2.5 percent potassium dichromate at room temperature for 48 to 72 hours, after which morphological features are evaluated [3].

An OPG count exceeding 5,000 oocysts per gram in a calf with compatible clinical signs is considered diagnostic for clinical coccidiosis [12]. However, lower counts do not exclude disease, particularly in early infection or when fecal shedding is intermittent. Subclinically infected calves may exhibit OPG values between 1,000 and 5,000 and still contribute to environmental contamination [10].

Advanced Diagnostic Methods

Molecular diagnostic approaches, including conventional polymerase chain reaction (PCR) targeting the internal transcribed spacer 1 (ITS-1) region of ribosomal DNA and species-specific quantitative PCR assays, offer superior sensitivity and specificity compared to microscopic methods [26, 30]. PCR-based methods enable definitive species identification even when oocyst morphology is ambiguous due to poor sporulation or low parasite burden.

Multiplex PCR panels capable of simultaneously detecting Eimeria spp., Cryptosporidium spp., and Giardia duodenalis have been developed for comprehensive enteric pathogen screening in calves [26, 27]. These assays are particularly valuable in differential diagnosis, as co-infections with Cryptosporidium parvum and bovine coronavirus are common and may confound clinical presentation [29].

Histopathological Examination

Postmortem diagnosis relies on histopathological evaluation of intestinal tissues. Characteristic lesions include typhlocolitis with mucosal hemorrhage, fibrinonecrotic exudate, and the presence of endogenous developmental stages (meronts, macrogamonts, microgamonts) within epithelial cells [14, 15]. The distribution of lesions correlates with the infecting species: E. bovis predominantly affects the cecum and colon, while E. zuernii also involves the distal small intestine [15].

Serum Biomarkers

Non-invasive assessment of intestinal damage using serum biomarkers has emerged as a complementary diagnostic tool. Calves with coccidiosis exhibit elevated serum concentrations of I-FABP, CLD-3, and IL-8, with I-FABP and CLD-3 levels significantly higher than in healthy controls before treatment [12]. Following successful therapy with toltrazuril, serum TFF-3 and ACTG2 levels increase, reflecting epithelial repair and restoration of intestinal barrier integrity [12]. Trace element profiling has also been investigated, with alterations in serum iron, copper, selenium, zinc, and cobalt concentrations documented in infected calves [25].

flowchart TD
    A["Calf with diarrhea or poor growth"], > B["Fecal sample collection (rectal or fresh void)"]
    B, > C{"Quantitative fecal flotation (McMaster)"}
    C, > D["OPG < 1,000"]
    C, > E["OPG 1,000 - 5,000"]
    C, > F["OPG > 5,000"]
    D, > G["Consider other enteric pathogens<br/>(Cryptosporidium, coronavirus, rotavirus)"]
    E, > H["Assess clinical signs"]
    H, > I["Clinical signs present"]
    H, > J["No clinical signs"]
    I, > K["Diagnose subclinical coccidiosis"]
    J, > L["Monitor; consider prophylactic treatment<br/>if risk factors present"]
    F, > M["Confirm species via sporulation or PCR"]
    M, > N["Initiate anticoccidial therapy<br/>(toltrazuril or amprolium)"]
    N, > O["Supportive care: fluids, electrolytes, nutrition"]
    O, > P["Recheck OPG 7-14 days post-treatment"]
    P, > Q{"OPG reduced by > 90%?"}
    Q, > R["Yes: Treatment successful"]
    Q, > S["No: Consider resistance or reinfection"]
    S, > T["Review biosecurity, rotate drug class"]
    T, > N

Figure 1. Diagnostic and therapeutic decision algorithm for bovine coccidiosis.

Treatment

Anticoccidial Drugs

The chemotherapeutic management of coccidiosis in calves relies on two primary classes of anticoccidial agents: triazinones (toltrazuril) and thiamine analogs (amprolium), in addition to ionophorous antibiotics (monensin, lasalocid, narasin) and sulfonamides.

Toltrazuril, a triazinone derivative, exerts anticoccidial activity by interfering with the respiratory metabolism and nuclear division of intracellular parasitic stages, including meronts and gamonts. A single oral dose of 15 mg/kg body weight administered during the late prepatent period significantly reduces oocyst excretion, decreases the frequency and severity of diarrhea, and improves weight gain in experimentally and naturally infected calves [4, 12, 15, 18]. The efficacy of toltrazuril following experimental infection with E. zuernii was demonstrated through significantly lower diarrhoea scores, reduced oocyst output, and higher weight gains compared to sham-treated controls [15]. In field outbreaks, a single treatment with toltrazuril (15 mg/kg) resulted in rapid clinical improvement and a marked reduction in OPG within 7 days [18].

Amprolium, a thiamine analog that competitively inhibits thiamine uptake by parasitic cells, is administered orally at 10 mg/kg body weight once daily for 5 to 7 consecutive days [4, 13]. The drug is most effective when initiated early in the course of infection, as it acts primarily on first-generation schizonts. Comparative efficacy studies have demonstrated that amprolium achieves 100 percent reduction in OPG by day 28 post-treatment, equivalent to toltrazuril and sulphaquinoxaline [4].

Ionophorous antibiotics, including monensin, lasalocid, and narasin, are polyether compounds that disrupt transmembrane ion gradients in parasitic cells, leading to osmotic lysis. Monensin fed at 16.5 to 33 g per metric ton of feed prevented clinical coccidiosis in experimentally infected calves and maintained weight gains comparable to non-infected controls [19]. Narasin at 0.8 mg/kg body weight and monensin at 1 mg/kg body weight demonstrated equivalent anticoccidial efficacy in naturally infected calves over a 42-day study period, although monensin exerted earlier suppression of oocyst shedding [10]. Lasalocid has also shown efficacy, with a reported 99 percent reduction in OPG at day 28 [4].

Sulfonamides, particularly sulphaquinoxaline, act by competing with para-aminobenzoic acid in the folic acid synthesis pathway of coccidia. Sulphaquinoxaline administered at recommended doses achieved 100 percent efficacy by day 28 in comparative trials [4]. However, the potential for tissue residues and the availability of more specific anticoccidials have limited its current use in many production systems.

Emerging and Alternative Therapies

The exploration of plant-based anticoccidials represents an active area of investigation. Powdered leaf and flower of Lobelia decurrens Cav. (contoya) administered at 2 g/kg body weight reduced OPG by 95.45 percent by day 15 in naturally infected heifers, with the 2 g/kg dose significantly outperforming the 1 g/kg dose (maximum efficacy 86.93 percent) [1]. These findings suggest that botanical preparations may offer a cost-effective and environmentally sustainable alternative to synthetic anticoccidials, particularly for small-scale producers.

Oxytetracycline, a broad-spectrum antibiotic, has been reported as an effective treatment for coccidiosis in calves despite its primary indication for bacterial infections. In a case series of Bunaji bull calves with hemorrhagic diarrhea and confirmed coccidial oocyst shedding, treatment with oxytetracycline combined with albendazole achieved successful clinical resolution [7]. The mechanism of action against coccidia is not fully defined but may involve inhibition of mitochondrial protein synthesis in apicomplexan parasites.

Supportive Therapy

Supportive care is essential in the management of clinical coccidiosis, particularly in calves with severe diarrhea and dehydration. Fluid therapy using isotonic electrolyte solutions administered intravenously (500 mL daily for 3 days) corrects dehydration and electrolyte imbalances [13]. Non-steroidal anti-inflammatory drugs may be indicated to reduce intestinal inflammation and tenesmus. Nutritional support, including provision of high-quality milk replacer or electrolyte solutions with added glucose, helps maintain energy balance during the anorexic phase.

Farm Management and Biosecurity

Environmental Contamination and Oocyst Survival

Eimeria oocysts are highly resistant to environmental conditions and can survive for months in moist, shaded environments, particularly in fecal-contaminated bedding, soil, and around feed and water sources. Sporulation, the process by which excreted unsporulated oocysts become infective, requires adequate oxygen, moisture, and temperatures between 20 and 30 degrees Celsius. Under favorable conditions, sporulation can occur within 48 to 72 hours [3].

Biosecurity Measures

Effective control of coccidiosis on farms requires an integrated approach combining hygiene, animal management, and strategic chemoprophylaxis. Key biosecurity measures include:

Hygiene and sanitation. Calf housing should be cleaned and disinfected between groups. Oocysts are resistant to many common disinfectants; however, 10 percent ammonia solution, steam cleaning, and desiccation under dry conditions can reduce environmental contamination. Bedding should be kept dry and replenished frequently. Feed and water troughs must be positioned to minimize fecal contamination.

Stocking density and group management. Overcrowding promotes oocyst accumulation and increases infection pressure. Calves should be housed in small, age-matched groups with adequate pen space. Mixing of different age cohorts should be avoided, as older calves may shed oocysts that infect younger, more susceptible animals [3, 8, 9].

All-in all-out management. The complete removal of animals between groups, followed by thorough cleaning and disinfection of facilities, breaks the parasite life cycle. Continuous occupancy of pens allows oocyst build-up and perpetuates infection.

Pasture management. Rotational grazing and avoiding turnout of naive calves onto heavily contaminated pastures reduces exposure risk. Coccidiosis outbreaks have been documented following turnout of calves onto permanent pastures grazed by previous cohorts [21].

Chemoprophylaxis

Strategic use of anticoccidial drugs during periods of peak risk can prevent clinical disease and reduce environmental contamination. Ionophores (monensin, lasalocid, narasin) are commonly incorporated into calf starter rations or milk replacers at recommended concentrations [10, 19]. Meta-analytical evidence supports the efficacy of ionophore feeding in reducing OPG and preventing diarrhea outbreaks.

Toltrazuril administered as a single dose (15 mg/kg) during the late prepatent period (approximately 10 to 14 days post-infection) is an effective prophylactic strategy in high-risk scenarios, such as after group mixing or at turnout [15, 18]. The timing of prophylactic treatment should be based on the known prepatent period of the predominant Eimeria species and the expected exposure risk.

Vaccination

Live vaccines containing attenuated Eimeria strains have been developed for cattle, although their availability varies by region. Vaccination aims to induce protective immunity through controlled exposure to low numbers of sporulated oocysts, stimulating both humoral and cell-mediated immune responses. Experimental studies have demonstrated that vaccination with irradiated or precocious lines of E. bovis and E. zuernii can reduce clinical signs and oocyst shedding upon challenge [11]. The practical application of vaccination in commercial calf rearing operations requires further evaluation of cost-effectiveness and protection duration.

Monitoring and Surveillance

Regular coprological monitoring provides early warning of rising infection pressure. Fecal samples should be collected from representative animals in each management group and examined by McMaster counting [3]. The identification of risk factors such as age, housing type, and presence of other animals allows targeted intervention [3, 9].

Conclusion

Coccidiosis remains a major constraint to calf health and productivity in cattle operations worldwide. The disease is caused by multiple Eimeria species, with E. bovis and E. zuernii being the most pathogenic. Accurate diagnosis depends on quantitative fecal examination using McMaster counting, supported by species identification through sporulation or molecular methods. Effective treatment options include toltrazuril, amprolium, and ionophorous antibiotics, each with demonstrated efficacy in reducing oocyst shedding and clinical signs. Plant-based alternatives such as Lobelia decurrens offer promising adjunctive or alternative therapies. Successful control requires an integrated farm management approach encompassing hygiene, stocking density management, all-in all-out housing, strategic chemoprophylaxis, and regular monitoring. The combination of biosecurity, targeted treatment, and surveillance provides the most sustainable pathway to reducing the economic impact of coccidiosis in calf rearing enterprises.

References

1. Torrel T, Valle J, Pérez F, et al. Efficacy of powdered leaf and flower of Lobelia decurrens Cav. to control coccidiosis in calves. Revista Colombiana de Ciencias Pecuarias.

2. Avellaneda-Cáceres A, Vitulli-Moya G, Colque-Caro L, et al. Case report outbreak of winter coccidiosis in calves from Northwestern Argentina.

3. Olivares-Muñoz A, Alonso-Díaz MÁ, Romero-Salas D, et al. Prevalence and risk factors of coccidiosis in calves from Veracruz, México. Revista Brasileira de Parasitologia Veterinária.

4. Sultana R, Ilyas S, Maqbool A, et al. Chemotherapy of coccidiosis in calves. Archives of Veterinary Science and Technology.

5. Verma R, Das G, Saiyam R, et al. Clinical coccidiosis in calves and its treatment.

6. Bayew K. Prevalence of coccidiosis in calves (study in Janamora Wereda).

7. Danbirni S, Kaltungo BY, Sulaiman MM, et al. Coccidiosis in two 6-month-old Bunaji bull-calves in Majeru village, Zaria L.G.A. of Kaduna State. Nigerian Journal of Animal Production.

8. Arslan M, Kırmızıgül AH, Parmaksizoglu N, et al. A case of winter coccidiosis in calves naturally infected by Eimeria zuernii.

9. Rodríguez-Vivas R, Dominguez-Alpizar JL, Torres-Acosta J. Epidemiological factors associated to bovine coccidiosis in calves (Bos indicus) in a sub-humid tropical climate.

10. Leiva T, Cooke R, Lasmar PVF, et al. Supplementing narasin or monensin to control coccidiosis in naturally infected calves. Translational Animal Science.

11. Sultana R, Maqbool A, Ahmad M, et al. Control of coccidiosis in calves by vaccination.

12. Durgut M, Ok M. Evaluation of some intestinal biomarkers in the determination of intestinal damage in calves with coccidiosis. Tropical Animal Science Journal.

13. Das M, Kumar R, Katiyar R. Coccidiosis in Murrah buffalo calves from Meghalaya's subtropical hilly region. Indian Journal of Veterinary Sciences and Biotechnology.

14. Jaiswal V, Brar A, Sandhu BS, et al. Faecal prevalence and histopathological evaluation of coccidiosis in bovine calves. Journal of Parasitic Diseases.

15. Mundt H, Bangoura B, Rinke M, et al. Pathology and treatment of Eimeria zuernii coccidiosis in calves: Investigations in an infection model. Parasitology International.

16. Prevalence of coccidiosis in calves in and around Debreberhan town.

17. Saravanajayam M, Srinivasan G, Binosundar ST. Hematological changes caused by coccidiosis and its therapeutic management in Pulikulam cattle calves. International Journal of Advanced Biochemistry Research.

18. Bohrmann R. Treatment with toltrazuril in a natural outbreak of coccidiosis in calves. DTW. Deutsche Tierarztliche Wochenschrift.

19. McDougald L. Monensin for the prevention of coccidiosis in calves. American Journal of Veterinary Research.

20. Wayuma H. Prevalence of calves coccidiosis in and around Mendi town, West Wollega, Oromia, Ethiopia. Biomedical Journal of Scientific and Technical Research.

21. Marshall R, Catchpole J, Green J, et al. Bovine coccidiosis in calves following turnout. The Veterinary Record.

22. Moberly A. Coccidiosis in calves. Indian Veterinary Journal.

23. Nikol'skii SN, Pozov SA. Comparative effectiveness of different preparations in coccidiosis in calves.

24. Fanelli H. Observations on "nervous" coccidiosis in calves. Bovine Practitioner.

25. Kozat S, Denizhan V. Evaluation of the concentrations of some trace elements (Fe, Cu, Se, Zn and Co) in calves naturally infected with coccidiosis. Journal of Elementology.

26. Yu Q, Chen S, Zhang X, et al. Genetic characterization and zoonotic potential of Cryptosporidium spp. and Giardia duodenalis in cattle from Northeast China. Transboundary and Emerging Diseases.

27. Gareh A, Elbarbary NK, Abd El-Halim MO, et al. Cryptosporidiosis at the human-ruminant interface in Aswan, Egypt: a one health epidemiological study using microscopy, immunofluorescence, and PCR. BMC Veterinary Research.

28. Shamsi L, Pouryousef A, Mohammadi MR, et al. Eimeria spp. in cattle: a global systematic review and meta-analysis. Veterinary Medicine and Science.

29. Varegg MS, Stokstad M, Bartley PM, et al. Cryptosporidium parvum and bovine coronavirus in naturally and experimentally exposed calves: clinical outcome and pathogen shedding. Veterinary Research.

30. Arsenopoulos KV, Chrysanthopoulos S, Papadopoulos E. Molecular investigation of Eimeria spp. infection in weaned dairy calves in Thessaly, Greece, and associated risk factors. International Journal of Molecular Sciences.